Galicaftor/Navocaftor/ABBV-119
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Galicaftor/Navocaftor/ABBV-119, covering 2024-07-16 to 2024-07-16. Get the full timeline:
Most recent: Clinical Trial Update: Study to Evaluate Adverse Events and Change in Disease Activity With Oral Capsules of Galicaftor/Navocaftor/ABBV-119 or Galicaftor/Navocaftor/ABBV-576 Combination Therapies in Adult Participants With Cystic Fibrosis [Phase 2]